Homocysteine has anti-inflammatory properties in a hypercholesterolemic rat model in vivo

Molecular and Cellular Neuroscience

Volumn 49, Issue 4, 2012, Pages 456-463

  Pirchl, Michael ^a   Ullrich, Celine ^a   Sperner Unterweger, Barbara ^a   Humpel, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alzheimer's Disease; Blood brain barrier; Cholesterol; Homocysteine; Inflammation; Spatial memory; Sprague Dawley rats; Tissue plasminogen activator

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE; LIPOPOLYSACCHARIDE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CORTEX; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; INFLAMMATION; LEARNING DISORDER; MEMORY DISORDER; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; HOMOCYSTEINE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEARNING; MALE; MEMORY DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84859044743     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.03.001     Document Type: Article

References (62)

1. Achón M., Alonso-Aperte E., Varela-Moreiras G., Selhub J. Mild methionine excess does not affect thymidylate synthesis or inflammation markers expression in human aortic endothelial cells. Ann. Nutr. Metab. 2009, 54:28-34.
2. Bienvenu T., Ankri A., Chadefaux B., Montalescot G., Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thromb. Res. 1993, 70:123-129.
3. Chandra V., Pandav R. Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology 1998, 17:225-232.
4. Collen D. The plasminogen (fibrinolytic) system. Thromb. Haemost. 1999, 82:259-270.
5. Dugas B., Charbonnier S., Baarine M., Ragot K., Delmas D., Ménétrier F., Lherminier J., Malvitte L., Khalfaoui T., Bron A., Creuzot-Garcher C., Latruffe N., Lizard G. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur. J. Nutr. 2010, 49:435-446.
6. Ehrlich D., Pirchl M., Humpel C. Effects of long-term moderate ethanol and cholesterol on cognition, cholinergic neurons, inflammation and vascular impairment in rats. Neuroscience 2012, 205:154-166.
7. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 2004, 61:668-672.
8. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000, 908:244-254.
9. Garcia A., Zanibbi K. Homocysteine and cognitive function in elderly people. C.M.A.J. 2004, 171:897-904.
10. Gorelick P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N.Y. Acad. Sci. 2010, 1207:155-162.
11. Granholm A.C., Bimonte-Nelson H.A., Moore A.B., Nelson M.E., Freeman L.R., Sambamurti K. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J. Alzheimers Dis. 2008, 14:133-145.
12. Gravanis I., Tsirka S.E. Tissue plasminogen activator and glial function. Glia 2005, 49:177-183.
13. Hajjar K.A. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J. Clin. Invest. 1993, 91:2873-2879.
14. Hajjar K.A., Mauri L., Jacovina A.T., Zhong F., Mirza U.A., Padovan J.C., Chait B.T. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J. Biol. Chem. 1998, 273:9987-9993.
15. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran L.J., Kohl B., Rao V., Kisiel W., Stern D.M., Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 2001, 107:675-683.
16. Humpel C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?. Exp. Gerontol. 2011, 46:225-232.
17. Humpel C., Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Curr. Neurovasc. Res. 2005, 2:341-347.
18. Humpel C., Weis C. Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. Implication in Alzheimer's disease?. J. Neural Transm. Suppl. 2002, 62:253-263.
19. Jeitner T.M., Voloshyna I., Reiss A.B. Oxysterol derivatives of cholesterol in neurodegenerative disorders. Curr. Med. Chem. 2011, 18:1515-1525.
20. Joffre C., Leclère L., Buteau B., Martine L., Cabaret S., Malvitte L., Acar N., Lizard G., Bron A., Creuzot-Garcher C., Bretillon L. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr. Eye Res. 2007, 32:271-280.
21. Kalayci R., Kaya M., Uzun H., Bilgic B., Ahishali B., Arican N., Elmas I., Küçük M. Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats. Int. J. Neurosci. 2009, 119:1881-1904.
22. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 1997, 42:776-782.
23. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. B.M.J. 2001, 322:1447-1451.
24. Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., Corcos L., Gambert P., Néel D., Lizard G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 2005, 21:97-114.
25. Lominadze D., Roberts A.M., Tyagi N., Moshal K.S., Tyagi S.C. Homocysteine causes cerebrovascular leakage in mice. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:1206-1213.
26. Marksteiner J., Humpel C. Beta-amyloid expression, release and extracellular deposition in aged rat brain slices. Mol. Psychiatry 2008, 13:939-952.
27. Marksteiner J., Kemmler G., Weiss E.M., Knaus G., Ullrich C., Mechteriakov S., Oberbauer H., Auffinger S., Hinterhölzl J., Hinterhuber H., Humpel C. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2011, 32:539-540.
28. Midorikawa S., Sanada H., Hashimoto S., Watanabe T. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem. Biophys. Res. Commun. 2000, 272:182-185.
29. Morello F., Saglio E., Noghero A., Schiavone D., Williams T.A., Verhovez A., Bussolino F., Veglio F., Mulatero P. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 2009, 207:38-44.
30. Morris M.S. Homocysteine and Alzheimer's disease. Lancet Neurol. 2003, 2:425-428.
31. Obeid R., McCaddon A., Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med. 2007, 45:1590-1606.
32. Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 2007, 9:1941-1958.
33. Pirchl M., Marksteiner J., Humpel C. Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease. Neurol. Res. 2006, 28:657-664.
34. Pirchl M., Ullrich C., Humpel C. Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats. Eur. J. Neurosci. 2010, 32:1516-1527.
35. Pirchl M., Kemmler G., Humpel C. Female Sprague Dawley rats show impaired spatial memory in the 8-arm radial maze under dim blue and red light. Int. J. Zool. 2010, http://www.hindawi.com/journals/ijz/2010/507524/, 10.1155/2010/507524.
36. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001, 103:2717-2723.
37. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., Athias A., Lemaire-Ewing S., Néel D., Petit J.M., Steinmetz E., Brenot R., Gambert P., Lizard G. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006, 69:359-373.
38. Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 2003, 6:345-351.
39. Raffai R.L., Weisgraber K.H. Cholesterol: from heart attacks to Alzheimer's disease. J. Lipid Res. 2003, 44:1423-1430.
40. Rahman S.M., Van Dam A.M., Schultzberg M., Crisby M. High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J. Neuroimmunol. 2005, 169:59-67.
41. Reijerkerk A., Kooij G., van der Pol S.M., Leyen T., van Het Hof B., Couraud P.O., Vivien D., Dijkstra C.D., de Vries H.E. Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J. Immunol. 2008, 181:3567-3574.
42. Rogove A.D., Siao C., Keyt B., Strickland S., Tsirka S.E. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J. Cell Sci. 1999, 112:4007-4016.
43. Rosklint T., Ohlsson B.G., Wiklund O., Norén K., Hultén L.M. Oxysterols induce interleukin-1beta production in human macrophages. Eur. J. Clin. Invest. 2002, 32:35-42.
44. Salimi K., Humpel C. Down-regulation of complement receptor 3 and major histocompatibility complex I and II antigen-like immunoreactivity accompanies ramification in isolated rat microglia. Brain Res. 2002, 946:283-289.
45. Salles F.J., Strickland S. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J. Neurosci. 2002, 22:2125-2134.
46. Schmidt-Kastner R., Meller D., Bellander B.M., Strömberg I., Olson L., Ingvar M. A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry. J. Neurosci. Methods 1993, 46:121-132.
47. Seeds N.W., Basham M.E., Ferguson J.E. Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J. Neurosci. 2003, 23:7368-7375.
48. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346:476-483.
49. Siao C.J., Tsirka S.E. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J. Neurosci. 2002, 22:3352-3358.
50. Simons M., Keller P., Dichgans J., Schulz J.B. Cholesterol and Alzheimer's disease: is there a link?. Neurology 2001, 57:1089-1093.
51. Sottero B., Gamba P., Gargiulo S., Leonarduzzi G., Poli G. Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr. Med. Chem. 2009, 16:685-705.
52. Speidl W.S., Nikfardjam M., Niessner A., Zeiner A., Jordanova N., Zorn G., Maurer G., Schreiber W., Wojta J., Huber K. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction. Thromb. Res. 2007, 119:331-336.
53. Takechi R., Galloway S., Pallebage-Gamarallage M.M., Lam V., Mamo J.C. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk. Prog. Lipid Res. 2010, 49:159-170.
54. Teesalu T., Hinkkanen A.E., Vaheri A. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am. J. Pathol. 2001, 159:2227-2237.
55. Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M.S., Bhat N.R. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem. 2008, 106:475-485.
56. Trousson A., Bernard S., Petit P.X., Liere P., Pianos A., El Hadri K., Lobaccaro J.M., Ghandour M.S., Raymondjean M., Schumacher M., Massaad C. 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J. Neurochem. 2009, 109:945-958.
57. Ullrich C., Pirchl M., Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol. Cell. Neurosci. 2010, 45:408-417.
58. Ullrich C., Pirchl M., Humpel C. Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices. Pharmacology 2010, 86:15-21.
59. Vejux A., Malvitte L., Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz. J. Med. Biol. Res. 2008, 41:545-556.
60. Weis C., Marksteiner J., Humpel C. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 2001, 102:129-138.
61. Xue Q.S., Sparks D.L., Streit W.J. Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production. J. Neuroinflammation 2007, 4:20.
62. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 2003, 112:1533-1540.